Ignite Creation Date:
2024-05-06 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 12:46 PM
Study NCT ID:
NCT03529110
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-12
First Post:
2018-04-13
Brief Title:
DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 HER2-Positive Unresectable andor Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane DESTINY-Breast03
Sponsor:
Daiichi Sankyo
Organization:
Daiichi Sankyo